Identification of biliary metabolites of ifosfamide using 31P magnetic resonance spectroscopy and mass spectrometry

Cancer Chemotherapy and Pharmacology

Volumn 56, Issue 4, 2005, Pages 409-414

  Payne, Geoffrey S ^a   Dzik Jurasz, Andrzej S K ^a,b   Mancini, Laura ^a   Nutley, Bernard ^c   Raynaud, Florence ^c   Leach, Martin O ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b EPIX Pharmaceuticals   (United States)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Biliary excretion; Glutathione; Ifosfamide; Magnetic resonance spectroscopy; Mass spectrometry

Indexed keywords

CARBOXYIFOSFAMIDE; DRUG METABOLITE; GLUTATHIONE; IFOSFAMIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DRUG BILE LEVEL; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG METABOLISM; EXTRACTION; GALLBLADDER; GLUTATHIONE METABOLISM; GUINEA PIG; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BILE; GUINEA PIGS; IFOSFAMIDE; MAGNETIC RESONANCE SPECTROSCOPY; MALE;

EID: 23244448027     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-005-1023-2     Document Type: Article

References (19)

1. Klaassen CD, Watkins JB (1984) 3rd Mechanisms of bile formation, hepatic uptake, and biliary excretion. Pharmacol Rev 36:1-67
2. Sigers CP, Watkins III JB (eds) (1991) Biliary excretion of drugs and other chemicals, 1st edn. Gustav Fischer Verlag, New York
3. Karachalios G, Charalabopoulos K (2002) Biliary excretion of antimicrobial drugs, Vol 48, pp 280-297
4. Klaassen CD (2002) Xenobiotic transporters: another protective mechanism for chemicals. Int J Toxicol 21:7-12
5. Clarke SJ, Rivory LP (1999) Clinical pharmacokinetics of docetaxel. Clin Pharmacokinet 36:99-114
6. Scripture CD, Pieper JA (2001) Clinical pharmacokinetics of fluvastatin. Clin Pharmacokinet, pp 263-281
7. Geubel AP, Sempoux CL (2000) Drug and toxin-induced bile duct disorders. J Gastroenterol Hepatol 15:1232-1238
8. Rossi AN, Rossi MB (1983) Meltzer-Lyon test simultaneous with fiberoptic gastroduodenoscopy. Surg Gynecol Obstet 157:378-379
9. Mancini L, Payne GS, Dzik-Jurasz AS, Leach MO (2003) Ifosfamide pharmacokinetics and hepatobiliary uptake in vivo investigated using single- and double-resonance 31P MRS. Magn Reson Med 50:249-255
10. Fleming RA (1997) An overview of cyclophosphamide and ifosfamide pharmacology. Pharmacotherapy 17:146S-154S
11. Martino R, Crasnier F, Chouini-Lalanne N, Gilard V, Niemeyer U, De Forni M, Malet-Martino M-C (1992) A new approach to the study of ifosfamide metabolism by the analysis of human body fluids with 31P nuclear magnetic resonance spectroscopy. J Pharmacol Experiment Therapeut 260:1133-1144
12. Gibson G, Skett P (2001) Introduction to Drug Metabolism, 3rd edn. Nelson Thorns
13. Prescot AP, Collins DJ, Leach MO, Dzik-Jurasz AS (2003) Human gallbladder bile: noninvasive investigation in vivo with single-voxel 1H MR spectroscopy. Radiology 229:587-592
14. Dzik-Jurasz AS, Collins DJ, Leach MO, Rowland IJ (2000) Gallbladder localization of (19)F MRS catabolite signals in patients receiving bolus and protracted venous infusional 5-fluorouracil. Magn Reson Med 44:516-520
15. Ransohoff DF, Gracie WA (1993) Treatment of Gallstones. Ann Intern Med 119:606-619
16. Kalliafas S, Ziegler DW, Flancbaum L, Choban PS (1998) Acute acalculous cholecystitis: incidence, risk factors, diagnosis, and outcome. Am Surg 64:471-475
17. Michielsen PP, Fierens H, Van Maercke YM (eds) (1992) Drug-induced gallbladder disease. Incidence, aetiol Manage 7:32-45
18. Adusumilli PS, Lee B, Parekh K, Farrelly PA (2002) Acalculous eosinophilic cholecystitis from herbal medicine: a review of adverse effects of herbal medicine in surgical patients. Surgery 131:352-356
19. Famularo G, Polchi S, De Simone C (1999) Acute cholecystitis and pancreatitis in a patient with biliary sludge associated with the use of ceftriaxone: a rare but potentially severe complication. Ann Ital Med Int 14:202-204